Premium
Teriparatide (recombinant human parathyroid hormone 1‐34) therapy in myeloma patients with severe osteoporosis and fractures despite effective anti‐myeloma therapy and bisphosphonates: A pilot study
Author(s) -
Diamond Terrence H.,
Golombick Terry,
Manoharan Arumugam,
Ramakrishna Rajeev,
Bryant Carl
Publication year - 2020
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25919
Subject(s) - medicine , teriparatide , multiple myeloma , osteoporosis , bone disease , bone resorption , parathyroid hormone , bone mineral , oncology , calcium
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom